Resurgence of yellow fever in Brazil: Overview and possible control options by Khan, Abdul Waheed et al.
LETTER TO THE EDITOR
RESURGENCE OF YELLOW FEVER IN BRAZIL:
OVERVIEW AND POSSIBLE CONTROL OPTIONS
ABDUL WAHEED KHAN1,2*, ZEESHAN NASIM3, FAZLI ZAHIR3,
MUHAMMAD ADIL KHAN3, ABID ALI4, SHAHID ALI2 and ABDUL HALEEM KHAN5
1Institute of Information Sciences, Academia Sinica, Taipei, Taiwan
2Center of Biotechnology and Microbiology, University of Swat, Odigram, Pakistan
3Institute of Biotechnology and Genetic Engineering, The University of Agriculture,
Peshawar, Pakistan
4Department of Zoology, Abdul Wali Khan University, Mardan, Pakistan
5Department of Zoology, Islamia College Peshawar, Peshawar, Pakistan
Dear Editor,
Brazil is one of the few countries with warm humid tropical weather,
offering conducive environment to the nourishment of tropical pathogens [1, 2].
Following the footprints of dengue [1] and Zika virus [2], yellow fever has
recently emerged as the new public health menace. The responsible agent of the
infection is an RNA virus of genus Flavivirus known as yellow fever virus.
Prominent symptoms comprise fever, loss of appetite, fatigue, nausea, and in
severe cases, bleeding and jaundice.
Since December 2016, Brazil is confronted with a new wave of yellow fever
outbreak [3]. The reckoned affectees include 586 conﬁrmed cases along with 190
conﬁrmed deaths (Table I) [4] (as of April 5, 2017). Furthermore, 450 incidence
cases and 49 suspected deaths are under investigation, making the ongoing
outbreak as the deadliest in the history of Brazil. In addition, 1,324 epizootic
deaths in primates have been reported to Ministry of Health, Brazil [5]. By now,
human yellow fever cases have originated in multiple states including Minas
Gerais, Espirito Santo, Rio de Janeiro, and Sao Paulo. All cases reported till date
have been associated with jungle mosquitoesHaemagogus and Sabethes [5]. With
the preexisting burden of Zika virus [2] and dengue [1], yellow fever outbreak is
another setback for country’s health and economic sector. The immunization pace
has been ampliﬁed and a total of 18.8 million doses of yellow fever vaccine have
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been distributed since January 2017 [5]. An extra 3.5 million doses requested by
Brazil have successfully arrived to address the vaccine-shortage issue [5].
Yellow fever virus transmission is maintained in tropical forests in a sylvatic
cycle involving mosquitoes and non-human primates [6] (monkeys and apes).
Generally, the infection spread in urban settings is facilitated by Aedes aegypti,
while in wild settings, Haemagogus janthinomys is the leading invasive mosquito
specie [7]. In prospect of the current outbreak, despite the rapid reactive targeted
vaccination, the virus dissemination is on its way [4, 5]. Indeed, by the time
reactive-targeted vaccination is completed, considerable numbers of susceptible
people are affected already by an ongoing outbreak. The current outbreak is
considered to be the deadliest in the history of Brazil with highest number of
morbidities (Figure 1). To date, the role of A. aegypti has not been reported [5];
nevertheless, if the infection is spread to urban settings, A. aegypti may become
active. In view of the present outbreak, there is a dire need of precautionary
measures to dilute the intensity of new cases. First, the practice of fumigation
should be conducted in the surroundings of residential colonies to curb the
nurturing of mosquitoes. Furthermore, use of mosquito repellents, safety nets,
and screens should be preferred to nullify chances of mosquito bite. Along with the
locals, travelers visiting Brazil should also take the vaccine for protection to
restrict the possible spread of infection to new regions [4, 5]. On part of the
government, awareness programs and campaigns should be started to convey
Table I. Distribution of yellow fever cases in various states of Brazil [4]
State
Cases Deaths
Suspected Conﬁrmed Total Suspected Conﬁrmed Total
Minas Gerais 287 426 713 38 138 176
Espirito Santo 98 142 240 6 43 49
Rio de Janeiro 19 9 28 1 1 2
Sao Paulo 8 5 13 1 4 5
Para 5 4 9 1 4 5
Parana 9 9
Bahia 8 8
Santa Catarina 6 6 1 1
Rio Grande do Sul 4 4
Amapa 1 1
Distrito Federal 1 1
Goias 1 1
Mato Grosso 1 1
Mato Grosso do Sul 1
Tocantins 1 1 1 1
Total 450 586 1,036 49 190 239
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precautionary measures and related information to the dwellers effectively. It is of
vital importance to inquire immune deﬁciencies (primary immune deﬁciency and
HIV-infected individuals) before vaccine administering.
In broader perspective, the world is now confronted with more infections
compared with the past. This is possibly due to global climatic changes and
gradual adaptation of the vector mosquitoes to a range of environmental factors
[7]. Interestingly, vector control is now an emerging area and hot topic for
infection control. Fortunately, many infectious diseases may share common/
related potential vectors. Therefore, hindering the potential vector would ensure
signiﬁcant decline in a range of vector-borne diseases. Along with conventional
vector control strategies, novel schemes are under evaluations recently. Some of
these practices have shown immense success in the past few years. These include
the new technique, i.e., release of insects carrying dominant lethal genes (RIDL)
genetic control strategy [8], which includes A. aegypti mass rearing. In this
strategy, genetically transformed A. aegypti expresses a repressible lethal gene.
During growth period, the supplied food supplement is not available in environ-
ment (e.g., tetracycline). The provided supplement represses the activation of
lethal gene. To mate with wild female, RIDL males are introduced in competition
with wild male. The resulting progeny mosquitoes perish as they lack dietary
supplement in wild. Another novel strategy involving infection of
A. aegypti with Wolbachia bacteria [9] has revealed remarkable decline in
transmission capability of A. aegypti for range of arboviral infection including
yellow fever. Recently, a similar study [10] revealed striking outcomes of
pyriproxyfen (synthetic analogue of insect juvenile hormone) in curtailing the
transmission capacity of A. aegypti. From the preliminary trials and studies on
Figure 1. Yellow fever morbidities in Brazil from 1980 till March 2017 [4]
YELLOW FEVER IN BRAZIL 355
Acta Microbiologica et Immunologica Hungarica 64, 2017
innovative vector control techniques, it is evident that there is a scope of further
improvement. Compared with the conventional chemical control, innovative
vector control techniques are environment-friendly. Therefore, along with practice
of immunization for routine outbreaks, there is a need of attention toward
enhancement in innovative vector control strategies for long-term goals. Hope-
fully, these novel strategies would reduce the current burden of vector-borne
diseases in future years.
References
1. Dias, L. L., Amerilla, A. A., Poloni, T. R., Covas, D. T., Aquino, V. H., Figueiredo, L. T.:
Detection of dengue virus in sera of Brazilian blood donors. Transfusion 52, 1667–1671
(2012).
2. Heukelbach, J., Alencar, C. H., Kelvin, A. A., Oliviera, W. K., Cavalcanti, L. P.: Zika
outbreak in Brazil. J Infect Dev Ctries 10, 116–120 (2016).
3. CNN: US ofﬁcials keep watchful eye on yellow fever outbreak in Brazil (2017). Available
at http://edition.cnn.com/2017/03/09/health/yellow-fever-outbreak-brazil/. Accessed 29
April 2017
4. European Centre for Disease Prevention and Control: Outbreak of yellow fever in Brazil –
First update, 13 April 2017. (2017). Available at http://ecdc.europa.eu/en/publications/
Publications/06-04-2017-RRA%20UPDATE%201-Yellow%20fever-Brazil.pdf. Accessed
30 April 2017
5. Relief web: Brazil works to control yellow fever outbreak, with PAHO/WHO support.
(2017). Available at http://reliefweb.int/report/brazil/brazil-works-control-yellow-fever-
outbreak-pahowho-support. Accessed 29 April 2017
6. Almeida, M. A., Santos, E. D., Cardoso, J. D., Fonseca, D. F., Noll, C. A., Silveira, V. R.,
Maeda, A. Y., de Souza, R. P., Kanamura, C., Brasil, R. A.: Yellow fever outbreak
affecting Alouatta populations in southern Brazil (Rio Grande do Sul State), 2008–2009.
Am J Primatol 74, 68–76 (2012).
7. Vasconcelos, P. F., Costa, Z. G., Travassos da-Rosa, E. S., Luna, E., Rodrigues, S. G.,
Baros, V. L., Dias, J. P., Monteiro, H. A., Oliva, E. F., Vasconcelos, H. B., Oliveira, R. C.,
Sausa, M. R., Barbosa Da Silva, J., Cruz, A. C., Martins, E. C., Travassos Da Ros, J. F.:
Epidemic of jungle yellow fever in Brazil, 2000: Implications of climatic alterations in
disease spread. J Med Virol 65, 598–604 (2001).
8. Ye,Y.H.,Carrasco,A.M.,Frentiu,F.D.,Chenoweth,S.F.,Beebe,N.W., vandenHurk,A.F.,
Simmons, C. P., O’Neill, S. L., McGraw, E. A.: Wolbachia reduces the transmission
potential of dengue-infected Aedes aegypti. PLoS Negl Trop Dis 9, e0003894 (2015).
9. Van den Hurk, A. F., Hall-Mendelin, S., Pyke, A. T., Frentiu, F. D., McElroy, K., Day, A.,
Higgs, S., Neill, S. L.: Impact of Wolbachia on infection with chikungunya and yellow
fever viruses in the mosquito vector Aedes aegypti. PLoS Negl Trop Dis 6, e1892 (2012).
10. Abad-Franch, F., Zamora-Perea, E., Luz, S. L.: Mosquito-disseminated insecticide for
citywide vector control and its potential to block arbovirus epidemics: Entomological
observations and modeling results from Amazonian Brazil. PLoS Med 14, e1002213 (2017).
356 KHAN ET AL.
Acta Microbiologica et Immunologica Hungarica 64, 2017
